Trial Profile
Diagnostic Efficacy of Gallium-PSMA-PET compared to Conventional Imaging in Lymph Node Staging of of 130 consecutive Patients with Intermediate to High-Risk Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2016
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 30 Dec 2015 New trial record
- 09 Dec 2015 Results published in the Journal of Urology